Viewing Study NCT01223456


Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2026-02-23 @ 1:32 PM
Study NCT ID: NCT01223456
Status: TERMINATED
Last Update Posted: 2013-10-08
First Post: 2010-10-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy Study of ONGLYZA (Saxagliptin) Under Conditions of Actual Use
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Saxagliptin View
None type 2 diabetes View
None clinical practice View